Mohammad Amin Sakr

Mohammad Amin Sakr

Auto-generated profile, based on publicly available information

Mohammad Amin Sakr

Department of Tropical Medicine

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MSMohammad Sakr
Mohammad Sakr
To describe the socio-demographic features, etiology, and risk factors for Budd-Chiari syndrome (BCS) in Egyptian patients. Ninety-four Egyptian patients with confirmed primary Budd-Chiari syndrome were presented to the Budd-Chiari Study Group (BCSG) and admitted to the Tropical Medicine Department of Ain Shams University Hospital (Cairo, Egypt). Complete clinical evaluation and laboratory investigations, including a thrombophilia workup and full radiological assessment, were performed to determine underlying disease etiologies. BCS was chronic in 79.8% of patients, acute or subacute in 19.1%, and fulminant in 1.1%. Factor V Leiden mutation (FVLM) was the most common etiological cause of disease (53.1%), followed by mutation of the gene encoding methylene tetrahydrofolate reductase (MTHFR) (51.6%). Current or recent hormonal treatment was documented in 15.5% of females, and BCS associated with pregnancy was present in 17.2% of females. Etiology could not be determined in 8.5% of patients. Males had significantly higher rates of MTHFR gene mutation and Behçet's disease, and females had significantly higher rates of secondary antiphospholipid antibody syndrome. A highly significant positive relationship was evident between the presence of Behçet's disease and inferior vena caval occlusion, either alone or combined with occlusion of the hepatic veins (P < 0.0001). FVLM is the most common disease etiology and MTHFR the second most common in Egyptian BCS patients. BCS etiology tends to vary with geographic region.

16 June 2006 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
TETarek M El‐Ghandour
Tarek M El‐Ghandour
MSMohammad A Sakr
Mohammad A Sakr
HEHatem El‐Sebai
Hatem El‐Sebai
TETarek F El‐Gammal
Tarek F El‐Gammal
MEManal H El‐Sayed
Manal H El‐Sayed

13 September 2016 in Liver International
Verified
Journal Article
Closed access
PDF file
MSMohammad Sakr
Mohammad Sakr
SASara M. Abdelhakam
Sara M. Abdelhakam
HDHany Dabbous
Hany Dabbous
AHAmr Hamed
Amr Hamed
ZHZeinab Hefny
Zeinab Hefny
AEAhmed Eldorry
Ahmed Eldorry

1 January 2017 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MSMohammad Sakr
Mohammad Sakr
SASara M Abdelhakam
Sara M Abdelhakam
SESoheir A Elsayed
Soheir A Elsayed
EAEnas H Allam
Enas H Allam
AFAmir M Farid
Amir M Farid
AEAhmed Eldorry
Ahmed Eldorry
To compare predictive ability of Budd-Chiari syndrome (BCS) prognostic indices (PIs) for one-year survival and Transjugular intrahepatic portosystemic shunt (TIPS) patency. This retrospective study enrolled 194 Egyptian patients with primary BCS who presented to the Budd-Chiari Study Group of Ain Shams University Hospital. Calculation of the available PIs was performed using Child-Pugh and model for end-stage liver disease scores, BCS-specific PIs (Clichy, New Clichy and Rotterdam) for all patients, and BCS-TIPS PI only for patients who underwent TIPS. The overall one-year survival rate and the one-year shunt patency rate for TIPS were reported. The overall one-year survival rate was 69.6%, and the New Clichy PI revealed the best validity for its prediction at a cut-off value of 3.75, with sensitivity and specificity of 78% and 73.3%, respectively [area under receiver operating characteristic curve (AUC) = 0.806]. The one-year survival rate post-TIPS was 89.7%, and the BCS-TIPS score demonstrated validity for its prediction at a cut-off value of 3.92 (sensitivity and specificity were 71.4% and 64.5%, respectively) (AUC = 0.715). Logistic regression analysis revealed that the New Clichy PI (P = 0.030), high serum total bilirubin (P = 0.047) and low albumin (P < 0.001) were independent factors for predicting mortality within one year. The one-year shunt patency rate in TIPS was 80.2%, and none of the PIs exhibited significant validity for its prediction. The New Clichy score could independently predict the one-year survival in Egyptian BCS patients.

3 August 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
FSFatma Shehata
Fatma Shehata
NMNihad Abdel Monem
Nihad Abdel Monem
MSMohamed Sakr
Mohamed Sakr
SKSamar Kasem
Samar Kasem
MBMahmoud Esmat Balbaa
Mahmoud Esmat Balbaa

2 January 2014 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
MEMahmoud El-Meteini
Mahmoud El-Meteini
HDHany Dabbous
Hany Dabbous
MSMohammad Sakr
Mohammad Sakr
AIAmany Ibrahim
Amany Ibrahim
IFIman Fawzy
Iman Fawzy
AEAhmed El-Dorry
Ahmed El-Dorry
Background: In the living donor liver transplant setting, the preoperative assessment of potential donors is important to ensure the donor safety. Objectives: The aim of this study was to identify causes and costs of living liver-donors rejection in the donation process. Materials and Methods: From June 2010 to June 2012, all potential living liver donors for 66 liver transplant candidates were screened at the Ain Shams Center for Organ Transplantation. Potential donors were evaluated in 3 phases, and their data were reviewed to determine the causes and at which phase the donors were rejected. Results: One hundred and ninety two potential living liver donors, including 157 (81.7%) males, were screened for 66 potential recipients. Of these, 126 (65.6%) were disqualified for the donation. The causes of rejection were classified as surgical (9.5 %) or medical (90.5 %). Five donors (3.9 %) were rejected due to multiple causes. Factor V Leiden mutation was detected in 29 (23 %) rejected donors (P = 0.001), 25 (19.8 %) donors had positive results for hepatitis serology (P = 0.005), and 16 (12.7 %) tested positive for drug abuse. Portal vein trifurcation (n = 9, 7.1%) and small size liver graft estimated by CT volumetric analysis (n = 6, 4.8 %) were the main surgical causes which precluded the donation. Conclusions: Among potential Egyptian living liver donors, Factor V Leiden mutation was a significant cause for live donor rejection. A stepwise approach to donor assessment was found to be cost-effective. Keywords: Liver Transplantation; Tissue Donors; Tissue Donors